Voyager Therapeutics, Inc.
USD3.59
-0.20 (-5.28%)
CEO
Alfred W. Sandrock Jr.
IPO Date
2015-11-11
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.81
Prev. Close
$3.79
Day Low
$3.58
Day High
$3.82
52W Low
$2.83
52W High
$5.55
Market Cap
$0.22B
Volume
0.63M
| 50,000 |
| $5.28 |
| 18 May 2026 | Quinlan Amy | Principal Accounting Officer | Disposed | 28,500 | $3.68 |
| 3 Apr 2026 | Sandrock Alfred | director, officer: President and CEO | S-Sale | Disposed | 11,511 | $3.87 |
| 3 Apr 2026 | Shiferman Gregory L. | SVP and General Counsel | A-Award | Acquired | 50,000 | $0.00 |
| 26 Feb 2026 | Swartz Robin | COO & CBO | S-Sale | Disposed | 6,458 | $3.77 |
| 26 Feb 2026 | Sandrock Alfred | director, officer: President and CEO | S-Sale | Disposed | 14,197 | $3.79 |
| 26 Feb 2026 | Jorgensen Nathan D. | Chief Financial Officer | S-Sale | Disposed | 4,668 | $3.77 |
| 26 Feb 2026 | Carter Todd Alfred | Chief Scientific Officer | S-Sale | Disposed | 4,174 | $3.76 |
| 20 Feb 2026 | Swartz Robin | COO & CBO | S-Sale | Disposed | 3,882 | $3.44 |